Brief: Biosynex H1 Operating Income Down At EUR 47 Mln
Oct 20 (Reuters) - BIOSYNEX SA ALBIO.PA :
* H1 REVENUE EUR 142.2 MILLION VERSUS EUR 225.2 MILLION YEAR
AGO
* H1 OPERATING INCOME EUR 47.0 MILLION VERSUS EUR 98.3
MILLION
YEAR AGO
* H1 CONSOLIDATED NET INCOME EUR 30.6 MILLION VERSUS EUR
70.5
MILLION YEAR AGO
* FOR 2022 AND 2023 EXPECTS NORMALISATION OF BUSINESS AROUND
COVID-19 PRODUCTS
Source text for Eikon: ID:nEQ5KYXc8a
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals